Established in June 2013, the Karolinska Institutet/AstraZeneca Integrated Cardio Metabolic Centre (KI-AZ ICMC) represents a unique and exciting opportunity for academic scientists to collaborate and work side-by-side with scientists from the pharmaceutical industry to discover and develop the next generation of medicines to treat cardiovascular and metabolic diseases.
Under the leadership of Professor Bo Angelin, nine open, integrated and collaborative research groups are focusing on preclinical and clinical studies. The aim of the centre is to advance the understanding of cardiovascular and metabolic disease within three main strategic areas:
- Cardiac Regeneration
- Islet Health (Diabetes)
- Diabetic Nephropathy